Singapore markets open in 8 hours 7 minutes

Ono Pharmaceutical Co., Ltd. (OPHLF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
15.960.00 (0.00%)
As of 09:46AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 6.95B
Enterprise value 6.13B
Trailing P/E 9.35
Forward P/E 13.87
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.40
Price/book (mrq)1.48
Enterprise value/revenue 0.01
Enterprise value/EBITDA 0.03

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 3-22.64%
S&P500 52-week change 325.01%
52-week high 320.63
52-week low 315.96
50-day moving average 316.47
200-day moving average 317.80

Share statistics

Avg vol (3-month) 3387
Avg vol (10-day) 3N/A
Shares outstanding 5469.71M
Implied shares outstanding 6475.38M
Float 8458.25M
% held by insiders 115.62%
% held by institutions 147.13%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.53
Forward annual dividend yield 43.31%
Trailing annual dividend rate 3110.00
Trailing annual dividend yield 3689.22%
5-year average dividend yield 4N/A
Payout ratio 429.17%
Dividend date 325 Jun 2018
Ex-dividend date 428 Mar 2024
Last split factor 25:1
Last split date 329 Mar 2016

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 25.62%
Operating margin (ttm)36.28%

Management effectiveness

Return on assets (ttm)12.49%
Return on equity (ttm)16.82%

Income statement

Revenue (ttm)498.07B
Revenue per share (ttm)1,029.06
Quarterly revenue growth (yoy)7.30%
Gross profit (ttm)N/A
EBITDA 190.01B
Net income avi to common (ttm)127.61B
Diluted EPS (ttm)1.71
Quarterly earnings growth (yoy)8.20%

Balance sheet

Total cash (mrq)135.56B
Total cash per share (mrq)285.53
Total debt (mrq)8.59B
Total debt/equity (mrq)1.09%
Current ratio (mrq)3.95
Book value per share (mrq)1,652.77

Cash flow statement

Operating cash flow (ttm)106.04B
Levered free cash flow (ttm)76.67B